DUBLIN--(BUSINESS WIRE)--The "Creatinine Measurement Market by Product, Test Type, Sample and End User , Region - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.
The global creatinine measurement market is expected to reach USD 564.5 million by 2023 from USD 377.2 million in 2018, at a CAGR of 8.4%.
Factors such as the increasing incidence of renal disorders, growing incidence of other chronic disorders impacting renal function, favorable government initiatives to promote renal health, rapid growth in the geriatric population, and the increasing number of drug development initiatives are driving the growth of the creatinine test kits and reagents market. On the other hand, identification of novel renal dysfunction biomarkers and frequently changing regulatory policies are expected to restrain the growth of this market to a certain extent.
Based on test type, the market is segmented into is segmented into Jaffe's kinetic method and enzymatic method. The enzymatic method segment is expected to grow at the highest CAGR during the forecast period owing to the advantages offered by this method such as high accuracy and specificity, low sample volume, and lack of interfering substances.
Based on type of sample the creatinine measurement market is segmented into blood/serum and urine samples. The blood/serum segment is expected to hold the largest share of the market and is also projected to grow at the highest CAGR during the forecast period. The large share of the blood/serum segment is primarily attributed to the benefits offered by this sample type, such as increased accuracy and low risk of contamination.
On the basis of end user, the creatinine measurement market is segmented into hospitals and diagnostic laboratories. In 2018, the hospitals segment is expected to account for the largest share of the creatinine measurement market. High patient influx, regular monitoring of kidney function by physicians (of patients with various disorders impacting kidney function) at hospitals, and the presence of an established and advanced diagnostic infrastructure are some of the major factors responsible for the large share of this end-user segment.
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Creatinine Test Kits and Reagents Market, By Product
7 Creatinine Test Kits and Reagents Market, By Type
8 Creatinine Test Kits and Reagents Market, By Sample Type
9 Creatinine Test Kits and Reagents Market, By End User
10 Creatinine Test Kits and Reagents Market, By Region
11 Competitive Landscape
12 Company Profiles
- Abbott Laboratories (US)
- Danaher Corporation (US)
- Dialab GmbH (Vienna)
- Diasys Diagnostic Systems GmbH (Germany)
- Diazyme Laboratories, Inc (US)
- F. Hoffmann-la Roche Ltd (Switzerland)
- Ortho Clinical Diagnostics (US)
- Pointe Scientific, Inc (US)
- Randox Laboratories (UK)
- Sentinel Ch. Spa. (Italy)
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China)
- Siemens Healthineers (Germany)
- Thermo Fisher Scientific Inc (US)
- Wako Pure Chemical Industries Ltd (Japan)
For more information about this report visit https://www.researchandmarkets.com/research/lcst66/creatinine?w=4